CCN Next Gen - Medical TOPR West 36C10G26R0003 0002-08 Amendment.pdf

5. PROJECT NUMBER (if applicable)

CODE 7. ADMINISTERED BY

2. AMENDMENT/MODIFICATION NUMBER

CODE

6. ISSUED BY

8. NAME AND ADDRESS OF CONTRACTOR

4. REQUISITION/PURCHASE REQ. NUMBER 3. EFFECTIVE DATE

9A. AMENDMENT OF SOLICITATION NUMBER

9B. DATED

PAGE OF PAGES

10A. MODIFICATION OF CONTRACT/ORDER NUMBER

10B. DATED

BPA NO. 1. CONTRACT ID CODE

FACILITY CODE CODE

Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods:

The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers

E. IMPORTANT:

is extended,

(a) By completing Items 8 and 15, and returning __________ copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted; or (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR

ACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY is not extended.

12. ACCOUNTING AND APPROPRIATION DATA

(REV. 11/2016)

is required to sign this document and return ___________ copies to the issuing office. is not, A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. IN ITEM 10A.

15C. DATE SIGNED

B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES

SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).

RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by letter or electronic communication, provided each letter or electronic communication makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:

D. OTHER

Contractor

16C. DATE SIGNED

14. DESCRIPTION OF AMENDMENT/MODIFICATION

16B. UNITED STATES OF AMERICA

Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.

15A. NAME AND TITLE OF SIGNER 16A. NAME AND TITLE OF CONTRACTING OFFICER

15B. CONTRACTOR/OFFEROR

STANDARD FORM 30 PREVIOUS EDITION NOT USABLE

Prescribed by GSA - FAR (48 CFR) 53.243

(Type or print) (Type or print)

(Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

(Number, street, county, State and ZIP Code)

(If other than Item 6)

(Specify type of modification and authority)

(such as changes in paying office, appropriation date, etc.)

(If required)

(SEE ITEM 11)

(SEE ITEM 13)

(X)

CHECK

ONE

13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS,

IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.

11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT

(Signature of person authorized to sign) (Signature of Contracting Officer)

1 15

0002-008 03-20-2026

36C10G

U.S. Department of Veterans Affairs

OPAL | Strategic Acquisition Center

10300 Spotsylvania Ave | STE 400

Fredericksburg VA 22408-2697

36C10G

U.S. Department of Veterans Affairs

OPAL | Strategic Acquisition Center

10300 Spotsylvania Ave | STE 400

Fredericksburg VA 22408-2697

To all Offerors/Bidders

36C10G26R0003

12-15-2025

X x x x

The purpose of this amendment (0002-08) is to:

1. Update language in the RFP for TOPR West.

2. Provide and update Attachment 3 – Price Schedule and Attachment Pa - CCN Legacy Vaccination_Medication Volumes

3. Publish an updated version of the full conformed copy for the CCN Next Gen Medical - TOPR 0002 West

4. All other terms and conditions remain the same.

All other terms and conditions remain the same.

Jessica Portillo

Contracting Officer

CONTINUATION PAGE 36C10G26R0003 0002-08

Note: The words in red font in the “To” sections of each change denote the new language to be added in each version.

1. This amendment provides revisions that have been incorporated into CCN Next Gen – Medical TOPR 0002 West – Conformed Copy and are detailed below for your reference.

CHANGE 1:

The following language in section E.1 ADDENDUM TO FAR 52.212-1 INSTRUCTIONS

TO OFFERORS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES,

FACTOR 4: PRICE, is hereby changed as follows:

FROM:

All proposals must include a Price Volume to be considered for award. The Pricing

Template in “Attachment 3 – CCN Next Gen Medical – West TOPR Price Schedule”, contains CLINs with varying pricing methodologies. The following CLINs and their corresponding Sub CLINs are pre-priced by VA: CLIN X001; CLIN X004; CLIN X005;

CLIN X009 and CLIN X010. The Offeror must propose pricing for all non-pre-priced

CLINs (i.e., populate all cells within the Price Schedule), including all CLINs identified as optional. Offerors must provide pricing for the base year and all option periods for all non-pre-priced CLINs. Failure to price the base and all option periods shall cause the offer to be rejected from further consideration. Offerors shall submit their prices using

“Attachment 3 – CCN Next Gen Medical – West TOPR Price Schedule,” and provide an explanatory narrative that the Offeror provides as the basis for their proposed price.

The Offeror’s completed Price Schedule constitutes its price proposal to the

Government. VA requires the Offeror to propose pricing for all non-pre-priced CLINs

(X002; X003; CLIN X006; X007; X008; X011; X012; X013; X014; X015; and X016), for each applicable year of the period of performance. Green colored cells require Offeror input. Gray colored cells are not priced by Offerors. Do not add or change gray cells.

The formulas, calculations, and links shall not be hidden. Print image files or files/worksheets containing only values are not acceptable.

TO:

All proposals must include a Price Volume to be considered for award. The Pricing

Template in “Attachment 3 – CCN Next Gen Medical – West TOPR Price Schedule v3”, contains CLINs with varying pricing methodologies. The following CLINs and their corresponding Sub CLINs are pre-priced by VA: CLIN X001; CLIN X004; CLIN X005;

CLIN X009 and CLIN X010. The Offeror must propose pricing for all non-pre-priced

CLINs (i.e., populate all cells within the Price Schedule), including all CLINs identified as optional. Offerors must provide pricing for the base year and all option periods for all non-pre-priced CLINs. Failure to price the base and all option periods shall cause the offer to be rejected from further consideration. Offerors shall submit their prices using

“Attachment 3 – CCN Next Gen Medical – West TOPR Price Schedule v3,” and provide an explanatory narrative that the Offeror provides as the basis for their proposed price.

The Offeror’s completed Price Schedule constitutes its price proposal to the

Government. VA requires the Offeror to propose pricing for all non-pre-priced CLINs

(X002, X003; CLIN X006; X007; X008; X011; X012; X013; X014; X015; and X016), for each applicable year of the period of performance. Green colored cells require Offeror input. Gray colored cells are not priced by Offerors. Do not add or change gray cells.

The formulas, calculations, and links shall not be hidden. Print image files or files/worksheets containing only values are not acceptable.

CHANGE 2:

The following language in section B.4 MEDICAL CLIN STRUCTURE is hereby changed as follows:

FROM:

CLIN X003, Seasonal Vaccinations:

CLIN X003, Seasonal Vaccinations, VA will pay the Contractor for administrating the influenza (trivalent, quadrivalent and high dosage), COVID-19 vaccines at retail pharmacies. Pricing for this CLIN is determined by the awarded price for each vaccination. CLIN X003 includes the administration and product fee.

TO:

CLIN X003, Seasonal Vaccinations and Adult Immunizations:

CLIN X003, Seasonal Vaccinations, VA will pay the Contractor for administrating the influenza (trivalent, quadrivalent and high dosage), COVID-19 vaccines, and VA approved adult immunizations at retail pharmacies. Pricing for this CLIN is determined by the Medicare rates and methodology for each vaccination. CLIN X003 includes the administration fee. See attachment Pa for VA approved adult immunizations.

CHANGE 3:

The following language in section B.4 MEDICAL CLIN STRUCTURE is hereby changed as follows:

FROM:

CLIN X006, Urgent and Emergent Medication:

CLIN X006, Urgent and Emergent Medication, VA will pay the Contractor for urgent and emergent medications dispensed by pharmacies in the Contractor's network without direct charges to the Veteran. VA will reimburse the Contractor for Brand Name (Sub

CLIN X006AA) and Generic (Sub CLIN X006AB) medication at the awarded prices based on a percentage of Average Sale Price (ASP). The Contractor shall invoice the

Dispensing fee (Sub CLIN X006AC) at the awarded price for each dispensing activity.

Sub CLIN X006AA Brand Name Medication

Sub CLIN X006AB Generic Medication

Sub CLIN X006AC Dispensing Fee

CLIN X007, Disaster Response ONLY – Urgent and Emergent Medication:

CLIN X007, Disaster Response ONLY – Urgent and Emergent Medication, VA will pay the Contractor for urgent and emergent medications dispensed by pharmacies in the

Contractor's network without direct charges to the Veteran during a specified and approved “Disaster Response” scenario. CLIN X007 will only be exercised in the case of a disaster that prevents VA’s mail order pharmacy from delivering medications to

Veterans. Prescription fills may be for 30-days under this CLIN. VA will reimburse the

Contractor for Brand Name (Sub CLIN X007AA) and Generic (Sub CLIN X007AB) medication at the awarded prices based on a percent of ASP. The Contractor shall invoice the Dispensing fee (Sub CLIN X007AC) at the awarded price for each dispensing activity.

Sub CLIN X007AA Brand Name Medication

Sub CLIN X007AB Generic Medication

Sub CLIN X007AC Dispensing Fee

CLIN X006, Urgent and Emergent Medication, VA will pay the Contractor for urgent and emergent medications dispensed by pharmacies in the Contractor's network without direct charges to the Veteran. VA will reimburse the Contractor for Brand Name (Sub

CLIN X006AA) and Generic (Sub CLIN X006AB) medication based on a percentage of

Average Wholesale Price (AWP). The Contractor shall invoice the Dispensing fee (Sub

CLIN X006AC) at the awarded price for each dispensing activity.

Sub CLIN X006AA Brand Name Medication

Sub CLIN X006AB Generic Medication

Sub CLIN X006AC Dispensing Fee

CLIN X007, Disaster Response ONLY – Urgent and Emergent Medication:

CLIN X007, Disaster Response ONLY – Urgent and Emergent Medication, VA will pay the Contractor for urgent and emergent medications dispensed by pharmacies in the

Contractor's network without direct charges to the Veteran during a specified and approved “Disaster Response” scenario. CLIN X007 will only be exercised in the case of a disaster that prevents VA’s mail order pharmacy from delivering medications to

Veterans. Prescription fills may be for 30-days under this CLIN. VA will reimburse the

Contractor for Brand Name (Sub CLIN X007AA) and Generic (Sub CLIN X007AB) medication based on a percent of AWP. The Contractor shall invoice the Dispensing fee

(Sub CLIN X007AC) at the awarded price for each dispensing activity.

Sub CLIN X007AA Brand Name Medication

Sub CLIN X007AB Generic Medication

Sub CLIN X007AC Dispensing Fee

CHANGE 4:

TO OFFERORS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES,

Directions for Pricing CLINs, is hereby changed as follows:

FROM:

CLIN X003, Seasonal Vaccinations:

Priced. Offerors shall propose a unit price, in dollars, to administer and dispense a single seasonal vaccine. The cost of the vaccination medications shall be captured under CLIN X001.

TO:

CLIN X003, Seasonal Vaccinations and Adult Immunizations:

Priced. Offerors shall propose a unit price, in dollars, to administer and dispense a single seasonal vaccine and VA approved adult immunization. The cost of the vaccination medications shall be captured under CLIN X001. Pricing for this CLIN is determined by the Medicare rates and methodology for each vaccination.

CHANGE 5:

TO OFFERORS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES,

Directions for Pricing CLINs, is hereby changed as follows:

FROM:

CLIN X006, Urgent and Emergent Medication:

SubCLIN X006AA, Brand Name Medication

Priced. Offerors shall propose a unit price for brand name medications, excluding dispensing fees, as a percentage of the ASP price, for each year of the Period of Performance.

SubCLIN X006AB, Generic Medication

Priced. Offerors shall propose a unit price, for generic medications, excluding dispensing fees, as a percentage of the ASP price, for each year of the Period of Performance.

SubCLIN X006AC, Dispensing Fee

Priced. Offerors shall propose a unit price, in dollars, for each medication that is dispensed for each year of the Period of Performance.

CLIN X007, Disaster Response ONLY - Urgent and Emergent Medication:

SubCLIN X007AA, Brand Name Medication

Priced. Offerors shall propose a unit price, for brand name mediations, excluding dispensing fees, as a percentage of the ASP price, for each year of the Period of Performance.

SubCLIN X007AB, Generic Medication

Priced. Offerors shall propose a unit price, for generic mediations, excluding dispensing fees, as a percentage of the ASP price, for each year of the Period of Performance.

SubCLIN X007AC, Dispensing Fee

Priced. Offerors shall propose a unit price, in dollars, for each medication that is dispensed, for each year of the Period of Performance.

SubCLIN X006AA, Brand Name Medication

Priced. Offerors shall propose a unit price for brand name medications, excluding dispensing fees, as a percentage of the AWP price, for each year of the Period of

Performance.

SubCLIN X006AB, Generic Medication

Priced. Offerors shall propose a unit price, for generic medications, excluding dispensing fees, as a percentage of the AWP price, for each year of the Period of

Performance.

SubCLIN X006AC, Dispensing Fee

Priced. Offerors shall propose a unit price, in dollars, for each medication that is dispensed for each year of the Period of Performance.

CLIN X007, Disaster Response ONLY - Urgent and Emergent Medication:

SubCLIN X007AA, Brand Name Medication

Priced. Offerors shall propose a unit price, for brand name mediations, excluding dispensing fees, as a percentage of the AWP price, for each year of the Period of

Performance.

SubCLIN X007AB, Generic Medication

Priced. Offerors shall propose a unit price, for generic mediations, excluding dispensing fees, as a percentage of the AWP price, for each year of the Period of Performance.

Priced/Evaluated.

SubCLIN X007AC, Dispensing Fee

Priced. Offerors shall propose a unit price, in dollars, for each medication that is dispensed, for each year of the Period of Performance.

CHANGE 6:

TO OFFERORS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES, 1.

General Instructions, is hereby incorporated as follows:

FROM:

a. This section provides requirements for preparing proposals, as well as specific instruction on the format and content of the proposal. Offerors are cautioned to follow the instructions provided in this section carefully to ensure the

Government receives consistent information. Each Offeror shall comply with the solicitation requirements and submit a clear, concise proposal that includes sufficient detail for the Government’s effective evaluation. The instructions describe the type and extent of information required and emphasize the significant areas to be addressed in the proposal. Review the Performance

Work Statement (PWS) and Attachments contained in this Task Order

Proposal Request (TOPR) for further insight into the areas that shall be addressed within the proposal. Proposals will be evaluated on the scheduled oral presentations and written information submitted by Offeror. Offerors shall submit a well-written proposal with adequately detailed information which clearly demonstrates compliance with the solicitation requirements and allows for a meaningful evaluation by the agency. Clarity and completeness are essential. Data not submitted with the proposal but submitted previously or presumed to be known (i.e. previous projects performed for the United States

Government) will not be considered as part of the proposal, except for Past

Performance. The Government intends to make single Task Order award from this solicitation. Multiple proposals from one Offeror will not be accepted in response to this solicitation.

b. The Offeror’s proposal shall include all the requested information and shall be submitted in accordance with these instructions. Failure to provide proposals in compliance with the instructions specified in this TOPR may render the

Offeror’s proposal incomplete, and that proposal may not be further evaluated for an award. Offerors are hereby advised that any Offeror-imposed terms and conditions and/or assumptions which deviate from the Government’s material terms and conditions established by the Solicitation, may render the

Offeror’s proposal Unacceptable, and thus ineligible for award.

c. The Offeror should not simply rephrase or restate the Government's requirements in its proposal. The Offeror shall provide a clear explanation that addresses how the Offeror intends to meet the requirements. Offerors shall assume that the Government has no prior knowledge of their facilities, capabilities and experience, or information presented in the Offeror’s proposal.

d. Offerors are advised that the Government will utilize The MITRE Corporation

(herein referred to as “MITRE”), Guidehouse, Agile4Vets, and Tria Federal to assist during the source selection. The exclusive responsibility for source selection will reside with the Government. Proprietary information submitted in response to this solicitation will be protected from unauthorized disclosure as required by Subsection 27 of the Office of Procurement Policy Act as amended (41 U.S.C. 423) (hereinafter referred to as "the Act") as implemented in FAR subpart 35.017. MITRE is a Federally Funded Research and Development Center (FFRDC) as authorized in 41 U.S.C. 1709(c) is bound contractually by Organizational Conflict of Interest and disclosure clauses with respect to proprietary information. Offerors personnel assisting in the proposal evaluation are procurement officials within the meaning of the

Act and will take all necessary action to preclude unauthorized use or disclosure of a competing Contractor's proprietary data.

e. The Government will evaluate proposals in accordance with the evaluation criteria set forth within this solicitation. This TOPR does not commit the

Government to pay any of the costs associated with the preparation and submission of the Offeror’s proposal.

f. The Offeror shall submit one (1) electronic (e-mail) copy of its proposal no later than the time specified in SF1449, Block 8, unless this date is changed via a formal amendment. The electronic copy of the Offeror’s proposals shall be submitted to the Contracting Officer identified on the SF1449.

g. The Government is not responsible for confirming receipt. In accordance with

FAR 52.212-1(c), Offerors are responsible for submitting proposals to reach the Government office designated in the solicitation by the date and time specified in the solicitation. The e-mail inboxes

CCNNextGenInquiries@va.gov are the Government office designated in the solicitation as defined in FAR 52.212-1(c) for timely receipt of proposals.

h. WARNING: Please do not wait until the last minute to submit your proposals!

Late proposals will not be accepted for evaluation. To avoid submission of late proposals, we recommend the transmission of your proposal file 24 hours prior to the required proposal due date and time. Please be advised that timeliness is determined by the date and time an Offeror’s proposal is received by the Government not when an Offeror attempted transmission.

Offerors are encouraged to review and ensure that sufficient bandwidth is available at the end of the transmission.

i. Acceptance Period. By submitting a proposal to this TOPR, the Contractor agrees that all pricing provided will remain valid and firm for a period of 365 calendar days from the date of submission and agrees to honor the submitted pricing without any adjustments during this period.

j. In addition, offerors must maintain continuous, uninterrupted registration in the

System for Award Management (SAM) https://sam.gov at the time of proposal submission, throughout the evaluation process, and at time of award.

k. As a result of this solicitation, the Government anticipates awarding a single https://sam.gov/

Task Order to the Offeror whose proposal conforms to the solicitation requirements and represents the Best Value to the Government.

l. Debriefings. The CO will notify Offerors of any decision to exclude them from the competitive range. Offerors excluded from the competitive range are entitled to no more than one debriefing in accordance with FAR 15.206, Offerors excluded from the competitive range, may request a pre-award debriefing or may choose to wait until after the source selection decision to request a post-award debriefing. The CO will notify unsuccessful Offerors in the competitive range of the source selection decision in accordance with FAR

15.205. Unsuccessful Offerors, upon such notification, may request a debriefing in accordance with FAR 15.205 or 15.206, as applicable.

TO:

a. This section provides requirements for preparing proposals, as well as specific instruction on the format and content of the proposal. Offerors are cautioned to follow the instructions provided in this section carefully to ensure the Government receives consistent information. Each Offeror shall comply with the solicitation requirements and submit a clear, concise proposal that includes sufficient detail for the Government’s effective evaluation. The instructions describe the type and extent of information required and emphasize the significant areas to be addressed in the proposal. Review the

Performance Work Statement (PWS) and Attachments contained in this Task

Order Proposal Request (TOPR) for further insight into the areas that shall be addressed within the proposal. Proposals will be evaluated on the scheduled oral presentations and written information submitted by Offeror. Offerors shall submit a well-written proposal with adequately detailed information which clearly demonstrates compliance with the solicitation requirements and allows for a meaningful evaluation by the agency. Clarity and completeness are essential. Data not submitted with the proposal but submitted previously or presumed to be known (i.e. previous projects performed for the United States

Government) will not be considered as part of the proposal, except for Past

Performance. The Government intends to make single Task Order award from this solicitation. Multiple proposals from one Offeror will not be accepted in response to this solicitation.

b. Socioeconomic Category Disclosure. Each Offeror shall disclose their socioeconomic category in their proposal. This information includes, but is not limited to, the following categories: Service-Disabled Veteran-Owned Small

Business (SDVOSB), Veteran-Owned Small Business (VOSB), Small

Business (SB), Women-Owned Small Business (WOSB), Economically

Disadvantaged Women-Owned Small Business (EDWOSB), Historically

Underutilized Business Zone Small Business (HUBZone SB), 8(a) Business

Development Program, Other Small Business, and Large Business. The

Offeror must clearly state their socioeconomic status in their proposal as follows:

1. [Company Name]

2. [UEI Number/CAGE Code]

3. [Socioeconomic Category]

For verification purposes, offerors classified under the small business socioeconomic categories must be registered and verified in the System for

Award Management (SAM) at https://www.sam.gov. Failure to provide the required socioeconomic information may result in the proposal being deemed non-responsive and rejected.

c. The Offeror’s proposal shall include all the requested information and shall be submitted in accordance with these instructions. Failure to provide proposals in compliance with the instructions specified in this TOPR may render the

Offeror’s proposal incomplete, and that proposal may not be further evaluated for an award. Offerors are hereby advised that any Offeror-imposed terms and conditions and/or assumptions which deviate from the Government’s material terms and conditions established by the Solicitation, may render the

Offeror’s proposal Unacceptable, and thus ineligible for award.

d. The Offeror should not simply rephrase or restate the Government's requirements in its proposal. The Offeror shall provide a clear explanation that addresses how the Offeror intends to meet the requirements. Offerors shall assume that the Government has no prior knowledge of their facilities, capabilities and experience, or information presented in the Offeror’s proposal.

e. If the Offeror believes that the requirements in these instructions contain an error, omission, or are otherwise unsound, the Offeror shall immediately notify the CO, in writing, provide supporting rationale and a proposed remedy for

CO consideration. The Government reserves the right to award this contract based on the initial proposal, as received, without discussions in accordance with FAR Alt I 52.215-1(f)(4).

f. Offerors are advised that the Government will utilize The MITRE Corporation

(herein referred to as “MITRE”), Guidehouse, Agile4Vets, and Tria Federal to assist during the source selection. The exclusive responsibility for source selection will reside with the Government. Proprietary information submitted in response to this solicitation will be protected from unauthorized disclosure as required by Subsection 27 of the Office of Procurement Policy Act as amended (41 U.S.C. 423) (hereinafter referred to as "the Act") as implemented in FAR subpart 35.017. MITRE is a Federally Funded Research https://www.sam.gov/ and Development Center (FFRDC) as authorized in 41 U.S.C. 1709(c) is bound contractually by Organizational Conflict of Interest and disclosure clauses with respect to proprietary information. Offerors personnel assisting in the proposal evaluation are procurement officials within the meaning of the

Act and will take all necessary action to preclude unauthorized use or disclosure of a competing Contractor's proprietary data.

g. The Government will evaluate proposals in accordance with the evaluation criteria set forth within this solicitation. This TOPR does not commit the

Government to pay any of the costs associated with the preparation and submission of the Offeror’s proposal.

h. The Offeror shall submit one (1) electronic (e-mail) copy of its proposal no later than the time specified in SF1449, Block 8, unless this date is changed via a formal amendment. The electronic copy of the Offeror’s proposals shall be submitted to the Contracting Officer identified on the SF1449.

i. The Government is not responsible for confirming receipt. In accordance with

FAR 52.212-1(c), Offerors are responsible for submitting proposals to reach the Government office designated in the solicitation by the date and time specified in the solicitation. The e-mail inboxes

CCNNextGenInquiries@va.gov are the Government office designated in the solicitation as defined in FAR 52.212-1(c) for timely receipt of proposals.

j. WARNING: Please do not wait until the last minute to submit your proposals!

Late proposals will not be accepted for evaluation. To avoid submission of late proposals, we recommend the transmission of your proposal file 24 hours prior to the required proposal due date and time. Please be advised that timeliness is determined by the date and time an Offeror’s proposal is received by the Government not when an Offeror attempted transmission.

Offerors are encouraged to review and ensure that sufficient bandwidth is available at the end of the transmission.

k. Acceptance Period. By submitting a proposal to this TOPR, the Contractor agrees that all pricing provided will remain valid and firm for a period of 365 calendar days from the date of submission and agrees to honor the submitted pricing without any adjustments during this period.

l. In addition, offerors must maintain continuous, uninterrupted registration in the

System for Award Management (SAM) https://sam.gov at the time of proposal submission, throughout the evaluation process, and at time of award.

m. As a result of this solicitation, the Government anticipates awarding a single

Task Order to the Offeror whose proposal conforms to the solicitation requirements and represents the Best Value to the Government.

n. Debriefings. The CO will notify Offerors of any decision to exclude them from https://sam.gov/ the competitive range. Offerors excluded from the competitive range are entitled to no more than one debriefing in accordance with FAR 15.206, Offerors excluded from the competitive range, may request a pre-award debriefing or may choose to wait until after the source selection decision to request a post-award debriefing. The CO will notify unsuccessful Offerors in the competitive range of the source selection decision in accordance with FAR

15.205. Unsuccessful Offerors, upon such notification, may request a debriefing in accordance with FAR 15.205 or 15.206, as applicable.

CHANGE 7:

The following changes in section D, CONTRACT DOCUMENTS, EXHIBITS, OR

ATTACHMENTS, D.1 CONTRACT ATTACHMENTS are as follows:

FROM:

See attached document: ATTACHMENT 3 – CCN Next Gen - Medical West TOPR

Price Schedule

TO:

See attached document: ATTACHMENT 3 – CCN Next Gen - Medical West TOPR

Price Schedule v3

CHANGE 8:

The following changes in section D, section D, CONTRACT DOCUMENTS, EXHIBITS, OR

ATTACHMENTS, D.2, PWS ATTACHMENTS are as follows:

FROM:

See attached document: ATTACHMENT P – Health Care Historical Volumes and

Estimated Enrollment and Eligibility

TO:

See attached document: ATTACHMENT P – Health Care Historical Volumes and

Estimated Enrollment and Eligibility

See attached document: ATTACHMENT Pa - CCN Legacy Vaccination_Medication

Volumes

CHANGE 9:

The following language in section E.1 ADDENDUM TO FAR 52.212-1 INSTRUCTIONS

TO OFFERORS—COMMERCIAL PRODUCTS AND COMMERCIAL

SERVICES, PRICE SCHEDULE is hereby changed as follows:

FROM:

The Price Schedule contains CLINs with varying pricing methodologies. VA requires the Offeror to propose pricing for all non-pre-priced CLINs, for each applicable year of the Period of Performance. The X in the CLIN number stands for the year of the contract, with zero being the base year (e.g., CLIN X001 in the base year is CLIN 0001). Refer to Section B.4, Medical CLIN Structure, for a description of each CLIN/subCLIN.

Calculations supporting the percentages may be submitted in the applicable tab in the “Attachment 3 – CCN Next Gen Medical – West TOPR Price Schedule”.

TO:

The Price Schedule contains CLINs with varying pricing methodologies. VA requires the Offeror to propose pricing for all non-pre-priced CLINs, for each applicable year of the Period of Performance. The X in the CLIN number stands for the year of the contract, with zero being the base year (e.g., CLIN X001 in the base year is CLIN 0001). Refer to Section B.4, Medical CLIN Structure, for a description of each CLIN/subCLIN.

Calculations supporting the percentages may be submitted in the applicable tab in the “Attachment 3 – CCN Next Gen Medical – West TOPR Price Schedule v3”.

CHANGE 10:

Section E.2 ADDENDUM TO FAR 52.212-2 EVALUATION— COMMERICAL ITEMS, Factor 4: Price, Evaluation Criteria (c ) is hereby changed as follows:

FROM:

c) Total Evaluated Price (TEP): To determine Best Value, the Government will use the

TEP for each Offeror. For purposes of evaluation, the Government will calculate the

Total Evaluated Price (TEP) using a standardized methodology that converts all proposed pricing inputs including unit-based pricing and percentage-based pricing into evaluated price values. Where percentages are required, the Government will apply the

Offeror’s proposed percentage rates to the applicable pricing assumptions, estimated quantities, or evaluation scenarios defined within the pricing template to derive a comparable evaluated dollar value. The TEP will then be calculated as the sum of all priced CLINs using this standardized approach.

c) Total Evaluated Price (TEP):

The Government will evaluate price for all Offerors in accordance with Section E. All pricing assumptions, Government-specified estimated quantities, and evaluation scenarios will be applied equally and without deviation across all Offerors to ensure a fair and consistent evaluation.

Unit-Priced CLINs. For CLINs priced on a unit basis, the Government will calculate the evaluated amount by multiplying the Offeror’s proposed unit price by the

Government-specified estimated quantity or volume for each year of the period of performance.

For example (for illustrative purposes only): if an Offeror proposes a unit price of $10 per vaccine and the Government estimates 5,000 vaccines, the evaluated amount for that CLIN is $50,000.

Percentage- or Rate-Based CLINs. For CLINs priced as a percentage or rate, the

Government will apply the Offeror’s proposed percentage or rate to the applicable

Government-calculated pricing assumptions, or estimated quantities, or evaluation scenarios for each year of the period of performance to derive a comparable evaluated dollar amount.

For example (for illustrative purposes only): if an Offeror proposes a rate of 110% and the Government’s calculated pricing assumption is $2,000,000, the evaluated amount for that CLIN is $2,200,000.

Total Evaluated Price (TEP). The evaluated amounts for all priced CLINs will be summed for each year of the period of performance and then aggregated across all years to determine each Offeror’s Total Evaluated Price (TEP). This standardized methodology ensures consistent comparison across all Offerors.”

ATTACHMENT:

• ATTACHMENT 3 – CCN Next Gen Medical - West TOPR Price Schedule v3

• ATTACHMENT Pa - CCN Legacy Vaccination_Medication Volumes

• CCN Next Gen Medical - TOPR 0002 West Conformed Copy